Medication adherence of a sample of hypertensive patients in the region of Sfax (Tunisia);Observance médicamenteuse chez un échantillon d'hypertendus dans la région de Sfax (Tunisie)

Annales de Cardiologie et d'Angeiologie

Volumn 59, Issue 3, 2010, Pages 131-137

  Ghozzi, H ^a   Kassis, M ^b   Hakim, A ^a   Sahnoun, Z ^a   Abderrahmen, A ^a   Abbes, R ^c   Maalej, S ^c   Hammami, S ^a   Hajkacem, L ^d   Zeghal, K ^a  

^a UNIVERSITY OF SFAX   (Tunisia)

^b HEDI CHAKER HOSPITAL   (Tunisia)

^c Polyclinique de la caisse nationale de sécurité sociale de Sfax ^*  (Tunisia)

^d Centre intermédiaire de soins et santé Elwassit   (Tunisia)

Author keywords

Compliance; pid miologie; Epidemiology; Hypertension; Observance

Indexed keywords

ANGIOTENSIN ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIURETIC AGENT;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; ASTHENIA; CONSULTATION; CONTROLLED STUDY; CORRELATION ANALYSIS; EDUCATIONAL STATUS; EPIGASTRIC PAIN; FEMALE; HUMAN; HYPERTENSION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT SATISFACTION; POLYURIA; QUESTIONNAIRE; TUNISIA;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; TUNISIA;

EID: 77953912700     PISSN: 00033928     EISSN: 17683181     Source Type: Journal    
DOI: 10.1016/j.ancard.2010.04.004     Document Type: Article

References (38)

1. Andrade J.P., Vilas-Boas F., Chagas H., Andrade M. Epidemiological aspects of adherence to the treatment of hypertension. Arq Bras Cardiol 2002, 79:380-384.
2. Lloyd-Jones D.M., Evans J.C., Levy D. Hypertension in adults across the age spectrum: current outcomes and control in community. JAMA 2005, 294:466-472.
3. Ghannem H., Hadj Fredj A. Transition épidémiologique et facteurs de risque cardiovasculaire en Tunisie. Rev Epidemiol Sante Publique 1997, 45:236-292.
4. Gascon J.J., Sanchez-Ortuno M., Llor B., Skidmore D., Sturno P.J. Why hypertensive patients do not comply with the treatment. Fam Pract 2004, 21:125-130.
5. Haynes R.B., Taylor D.w., Sackett D.L. Compliance in health care 1979, Johns HopKins University Press, Baltimore.
6. Joint National Committee on prevention, detection evaluation and treatment of high blood pressure. The sixth report of the Joint National Committee on prevention. Arch Intern Med 1997;157:2413.
7. Hyman D.J., Pavlik V.N. Uncontrolled hypertension as a risk for coronary artery disease: patient characteristics and the role of physician intervention. Curr Atheroscler Rep 2003, 5(2):131-138.
8. Nelson M.R., Reid C.M., Ryan Ph., Willson K., Yelland L. Self-reported adherence with medication and cardiovascular disease outcomes in the Second Australian National Blood Pressure Study (ANBP2). Med J Aust 2006, 185(9):487-489.
9. Williams B., Poulter N.R., Brown M.J., David M., Mcinnes G.T., Potter J.F., et al. British hypertension society guidelines for hypertension management 2004 (BHS-IV). BMJ 2004, 328:634-640.
10. Girerd X., Hanon O., Anagnostopoulos K., Ciupek C., Mourad J.J., Consoli S. Évaluation de l'observance du traitement antihypertenseur par un questionnaire: mise au point et utilisation dans un service spécialisé. Presse Med 2001, 30:1044-1048.
11. Guidelines Sub Committee 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens, 1999;17:151-83.
12. Ambrosioni E., Leonetti G., Pessina A.C., Rappelli A., Trimarco B., Zanchetti A. Patterns of hypertension management in Italy: results of a pharmacoedipemiological survey on anthypertensive therapy. Scientific Committee of the Italian pharmaco-epidemiological survey on antihypertensive therapy. J Hypertens 2000, 18:1691-1699.
13. Ben Abdelaziz A., Ben Dourou D., Gaha R., Lazreg F., Kallel O., Ghannem H. Évaluation de l'observance thérapeutique des malades chroniques dans une commune semi-urbaine du Sahel tunisien. Microb Hyg Ali 2003, 15:54-59.
14. Ben Abdelaziz A., Ben Othman A., Mandhouj, Gaha R., Bouabid Z., Ghannem H. Audit of management of arterial hypertension in primary health care in Sousse. Tunis Med 2006, 84(3):148-154.
15. Girerd X., Radauceanu A., Achard J.M., Fourcade J., Tournier B., Brillet G., et al. Évaluation de l'observance par I'interrogatoire au cours du suivi des hypertendus dans des consultations spécialisées. Arch Mal Coeur Vaiss 2001, 94:839-842.
16. Claxton A., Cramer J.A., Pierce C. A systematic review of the associations between dose regime and medication compliance. Clin Ther 2001, 23:1296-1310.
17. Iskedjian M., Einarson T.R., Mackeigan L.D., Shear N., Addis A., Mittmann N., et al. Relation between daily frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis. Clin Ther 2002, 24:302-316.
18. Giacomin M.K., Cook D.J. Qualitative research in health care. What are the results and do they help me care for my patients?. JAMA 2000, 284:478-482.
19. Nuesch R., Schroeder K., Dieterie T., Martina B., Battegay E. Relation between insufficient response to antihypertensive treatment and poor compliance with treatment: a prospective case-control study. BMJ 2001, 323:21.
20. Patel R.P., Taylor S. Factors affecting medication adherence in hypertensive patients. Ann Pharmacother 2002, 36:40-45.
21. Caro J.J., Salas M., Speckman J.L., Raggio G., Jackson J.D. Persistence with treatment for hypertension in actual practice. CMAJ 1999, 160:31-37.
22. Jokisalo E., Kumpusalo E., Enlund H., Takala J. Patients' perceived problems with hypertension and attitudes towards medical treatment. J Hum Hypertens 2001, 15:755-761.
23. McClellan W.M., Hall W.D., Brogan D., Miles C., Wilber J.A. Continuity of care in hypertyension. An important correlate of blood pressure control among aware hypertensives. Arch Intern Med 1988, 148:525-528.
24. Kyngas H., Lahdenpera T. Compliance of patient with hyperpension and associated factors. J Adv Nurs 1999, 29:832-839.
25. Balkrishnan R. Predictors of medication adherence in the elderly. Clin Ther 1998, 20:764-771.
26. Heise T., Jennen E., Hochlenert D., Weyer C., Sawicki P.T. Results of a structured hypertension teaching and treatment programme. Z Gastroenterol 2002, 40:527-532.
27. Hyman D.J., Pavlik V.N. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 2001, 345:479-486.
28. Othene Buabeng K., Matowe L., Plange- Rhule J. Unaffordable drug prices: the major cause of non-compliance with hypertension medication in Ghana. J Pharm Pharm Sci 2004, 7:350-352.
29. Navarro R., Rivera J., Rosado A., Ruiz H., Iriarte R.I. Compliance with current therapy guidelines in hypertensive patients at an emergency service. Bol Asoc Med 2004, 96(4):209-217.
30. Nourris S.L., Engelgou M.M., Venkat Narayan K.M. Effectiveness of self-management training in type 2 diabetes. Diabetes Care 2001, 24:566-587.
31. Ferrières J., Durak-Bown I., Giral P., Chadarevian R., Benkritly A., Bruckert E. Éducation thérapeutique et patient à haut risque: une nouvelle approche en cardiologie. Ann Cardiol Angeiol 2006, 55:27-31.
32. Saounatsou M., Patsi O., Fasoi G., Stylianou M., Kavga A., Economou O., et al. The influence of the hypertensive patients education in compliance with their medication. Public Health Nurs 2001, 18:436-442.
33. Gil V., Munoz C., Martinez J.L., Belda J., Soriano J.E., Merino J. Factors involved in the hypertensive patient noncompliance with treatment. Med Clin 1994, 102:50-53.
34. Vaur L., Vaisse B., Genes N., Elfik F., Legrand C., Poggi L. Use of electronic pill boxes to assess risk of poor treatment compliance. Results of a large-scale trial. Am J Hypertens 1999, 12:374-380.
35. Bloom B.S. Daily regimen and compliance with fewer side effects improve compliance. BMJ 2001, 323:647.
36. Kiortsis D.N., Giral P., Bruckert E., Turpin G. Factors associated with low compliance with lipid-lowering drugs in hyperlipidemic patients. J Clin Pharm Ther 2000, 25:445-451.
37. Svensson S., kjellgren Kl, Ahlner J., Saljo R. Reasons for adherence with antihypertensive medication. Int J Cardiol 2000, 76:157-163.
38. Stephenson J. Noncompliance may cause half of antihypertensive drug " failures" JAMA 1999, 282:313-314.